Sinobiopharma, Inc.has appointed Xinjie (James) Mu as the new CFO and as a director on the Board.
Mu has more than 12 years experience in the financial field. Most recently, Mu has been an independent consultant working for China based US public companies. Prior to that, he was a CFO at Jingwei International Limited. Prior to that, he served as a senior accountant at Geller and Company in New York City. Mu is also a Director of China Infrastructure Investment Corporation since March 2008. Fluent in Mandarin and English, Mu holds a Bachelor of Science degree from Hebei University of Science and Technology, and a Master of Business Administration from Baruch College at the City University of New York.